Shanmugam Muthusamy 4
4 · ANI PHARMACEUTICALS INC · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
ANI Pharmaceuticals (ANIP) COO Shanmugam Muthusamy Sells 2,898 Shares
What Happened Shanmugam Muthusamy, Head of R&D, COO‑Novitium Ops and director at ANI Pharmaceuticals, had 2,898 shares disposed of (withheld) to satisfy tax obligations related to equity vesting. The filing reports a disposition of 2,898 shares at $76.25 per share, totaling approximately $220,973. This transaction is coded F (shares withheld for tax purposes) — not an open‑market sale by the insider.
Key Details
- Transaction date: 2026-02-11; filing date: 2026-02-13 (filed within the typical two-business-day window).
- Price: $76.25 per share; Shares withheld/disposed: 2,898; Total value: $220,973.
- Shares owned after the transaction: not stated in the provided filing excerpt.
- Footnotes of note:
- F1: Shares were withheld to cover taxes on the vesting of 11,578 performance stock units (grant originally reported Apr 6, 2023).
- F2: Includes 250 shares acquired under the company ESPP (exempt under Rule 16b-3).
- F3 & F4: Reporting person holds voting and dispositive power over shares held by Esjay LLC and SS Pharma LLC.
- Transaction code meaning: F = tax withholding (company retained shares to cover tax liability).
Context Tax‑withholding dispositions are routine administrative actions when restricted or performance equity vests and do not necessarily signal insider sentiment. Unlike an open‑market sale, these shares were retained by the company to satisfy taxes rather than sold by the insider for cash.
Insider Transaction Report
- Tax Payment
Common Stock
[F1][F2]2026-02-11$76.25/sh−2,898$220,973→ 89,940 total
- 431,920(indirect: By LLC)
Common Stock
[F3] - 5,000(indirect: By LLC)
Common Stock
[F4]
Footnotes (4)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023.
- [F2]Includes 250 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).
- [F3]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F4]The reporting person holds voting and dispositive power over the shares held by SS Pharma LLC.